Abstract
Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary prevention of recurrent stroke has been controversial. Publication of high-quality evidence from randomized clinical trials and the subsequent FDA approval of two devices for percutaneous PFO closure is expected to increase the volume of PFO closure procedures not only in the United States but worldwide. As this technology is disseminated broadly to the public, ensuring the safe and efficacious performance of PFO closure is essential to mitigate risk and avoid unnecessary procedures. This document, prepared by a multi-disciplinary writing group convened by the Society for Cardiovascular Angiography and Interventions and including representatives from the American Academy of Neurology, makes recommendations for institutional infrastructure and individual skills necessary to initiate and maintain an active PFO/stroke program, with emphasis on shared decision making and patient-centered care.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 859-874 |
| Number of pages | 16 |
| Journal | Catheterization and Cardiovascular Interventions |
| Volume | 93 |
| Issue number | 5 |
| DOIs | |
| State | Published - Apr 1 2019 |
Fingerprint
Keywords
- ASD/PDA/PFO
- closure
- comparative effectiveness/patient centered outcomes research
- evidence-based medicine
- structural heart disease intervention
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine
Cite this
SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke : The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. / Horlick, Eric; Kavinsky, Clifford J.; Amin, Zahid; Dean Boudoulas, Konstantinos; Carroll, John D.; Hijazi, Ziyad M.; Leifer, Dana; Lutsep, Helmi L.; Rhodes, John F.; Tobis, Jonathan M.
In: Catheterization and Cardiovascular Interventions, Vol. 93, No. 5, 01.04.2019, p. 859-874.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke
T2 - The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
AU - Horlick, Eric
AU - Kavinsky, Clifford J.
AU - Amin, Zahid
AU - Dean Boudoulas, Konstantinos
AU - Carroll, John D.
AU - Hijazi, Ziyad M.
AU - Leifer, Dana
AU - Lutsep, Helmi L.
AU - Rhodes, John F.
AU - Tobis, Jonathan M.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary prevention of recurrent stroke has been controversial. Publication of high-quality evidence from randomized clinical trials and the subsequent FDA approval of two devices for percutaneous PFO closure is expected to increase the volume of PFO closure procedures not only in the United States but worldwide. As this technology is disseminated broadly to the public, ensuring the safe and efficacious performance of PFO closure is essential to mitigate risk and avoid unnecessary procedures. This document, prepared by a multi-disciplinary writing group convened by the Society for Cardiovascular Angiography and Interventions and including representatives from the American Academy of Neurology, makes recommendations for institutional infrastructure and individual skills necessary to initiate and maintain an active PFO/stroke program, with emphasis on shared decision making and patient-centered care.
AB - Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary prevention of recurrent stroke has been controversial. Publication of high-quality evidence from randomized clinical trials and the subsequent FDA approval of two devices for percutaneous PFO closure is expected to increase the volume of PFO closure procedures not only in the United States but worldwide. As this technology is disseminated broadly to the public, ensuring the safe and efficacious performance of PFO closure is essential to mitigate risk and avoid unnecessary procedures. This document, prepared by a multi-disciplinary writing group convened by the Society for Cardiovascular Angiography and Interventions and including representatives from the American Academy of Neurology, makes recommendations for institutional infrastructure and individual skills necessary to initiate and maintain an active PFO/stroke program, with emphasis on shared decision making and patient-centered care.
KW - ASD/PDA/PFO
KW - closure
KW - comparative effectiveness/patient centered outcomes research
KW - evidence-based medicine
KW - structural heart disease intervention
UR - http://www.scopus.com/inward/record.url?scp=85063998786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063998786&partnerID=8YFLogxK
U2 - 10.1002/ccd.28111
DO - 10.1002/ccd.28111
M3 - Article
C2 - 30896894
AN - SCOPUS:85063998786
VL - 93
SP - 859
EP - 874
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
SN - 1522-1946
IS - 5
ER -